Global burden of COPD
- PMID: 26494423
- DOI: 10.1111/resp.12660
Global burden of COPD
Abstract
It is estimated that the world population will reach a record 7.3 billion in 2015, and the high burden of chronic conditions associated with ageing and smoking will increase further. Respiratory diseases in general receive little attention and funding in comparison with other major causes of global morbidity and mortality. In particular, chronic obstructive pulmonary disease (COPD) has been a major public health problem and will remain a challenge for clinicians within the 21st century. Worldwide, COPD is in the spotlight, since its high prevalence, morbidity and mortality create formidable challenges for health-care systems. This review emphasizes the magnitude of the COPD problem from a clinician's standpoint by drawing extensively from the new findings of the Global Burden of Disease study. Updated, distilled information on the population distribution of COPD is useful for the clinician to help provide an appreciation of the relative impact of COPD in daily practice compared with other chronic conditions, and to allocate minimum resources in anticipation of future needs in care. Despite recent trends in reduction of COPD standardized mortality rates and some recent successes in anti-smoking efforts in a number of Western countries, the overarching demographic impact of ageing in an ever-expanding world population, joined with other factors such as high rates of smoking and air pollution in Asia, will ensure that COPD will continue to pose an ever-increasing problem well into the 21st century.
Keywords: burden; chronic obstructive pulmonary disease; mortality; prevalence; underdiagnosis.
© 2015 Asian Pacific Society of Respirology.
Similar articles
-
Chronic obstructive pulmonary disease: a worldwide problem.Med Clin North Am. 2012 Jul;96(4):671-80. doi: 10.1016/j.mcna.2012.02.005. Med Clin North Am. 2012. PMID: 22793937 Review.
-
Chronic obstructive pulmonary disease in women: exploring gender differences.Curr Opin Pulm Med. 2004 Mar;10(2):98-103. doi: 10.1097/00063198-200403000-00003. Curr Opin Pulm Med. 2004. PMID: 15021178 Review.
-
Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation.Proc Am Thorac Soc. 2011 Aug;8(4):363-7. doi: 10.1513/pats.201102-017RM. Proc Am Thorac Soc. 2011. PMID: 21816993 Review.
-
Chronic obstructive pulmonary disease deaths, disability-adjusted life years, and risk factors in Hubei province of mid-China, 1990-2015: the Global Burden of Disease Study 2015.Public Health. 2018 Aug;161:12-19. doi: 10.1016/j.puhe.2018.02.016. Epub 2018 May 28. Public Health. 2018. PMID: 29852340
-
Epidemiology and global impact of chronic obstructive pulmonary disease.Semin Respir Crit Care Med. 2005 Apr;26(2):204-10. doi: 10.1055/s-2005-869539. Semin Respir Crit Care Med. 2005. PMID: 16088437 Review.
Cited by
-
Circ-OSBPL2 Contributes to Smoke-Related Chronic Obstructive Pulmonary Disease by Targeting miR-193a-5p/BRD4 Axis.Int J Chron Obstruct Pulmon Dis. 2021 Apr 7;16:919-931. doi: 10.2147/COPD.S298465. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33854310 Free PMC article.
-
Association of toll-like receptors polymorphisms with COPD risk in Chinese population.Front Genet. 2022 Oct 26;13:955810. doi: 10.3389/fgene.2022.955810. eCollection 2022. Front Genet. 2022. PMID: 36386838 Free PMC article.
-
Pulmonary rehabilitation ameliorates regional lung function in chronic obstructive pulmonary disease: a prospective single-arm clinical trial.Ann Transl Med. 2022 Aug;10(16):891. doi: 10.21037/atm-22-3597. Ann Transl Med. 2022. PMID: 36111029 Free PMC article.
-
Integrative weighted molecular network construction from transcriptomics and genome wide association data to identify shared genetic biomarkers for COPD and lung cancer.PLoS One. 2022 Oct 4;17(10):e0274629. doi: 10.1371/journal.pone.0274629. eCollection 2022. PLoS One. 2022. PMID: 36194576 Free PMC article.
-
The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker.Int J Mol Sci. 2022 Oct 29;23(21):13180. doi: 10.3390/ijms232113180. Int J Mol Sci. 2022. PMID: 36361969 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical